Guangxi Hongxiang Yixintang Pharmaceutical Co., Ltd. announced that it will receive CNY 39,000,000 in an equity round of funding from existing investor Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. on November 13, 2014. The investor will continue to hold 100% stake in the company upon completion of the transaction. The registered capital of the company will increase from CNY 70,000,000 to CNY 109,000,000 upon completion of the transaction. On the same date, the transaction was approved at the 5th extraordinary shareholders' meeting of 2014 of the investor.

On January 12, 2015, Guangxi Hongxiang Yixintang Pharmaceutical Co., Ltd. closed the transaction. The company obtained business license approved and issued by the Administration of Commerce and Industry and completed its change of business registration.